STOP2030

#STOP2030 at a glance! ▶ Discover our project and meet the partners with our newly launched presentation video. All you need to know about our novel co-formulation for #STH in under 5 minutes — watch now! https://lnkd.in/dMNqNH2x

In late 2023, Bridges celebrated its fifth anniversary. This was a time to both reflect on the years and celebrate how far we have come since launching in 2018. We took this opportunity to define a new, even more ambitious strategy for the next five years (2024 –2028), to advance our mission to support resilient communities on a path to sustainable development. We are proud of our collaborations and projects over the last five years and are excited to see what the future holds. Over these short years, we have built a strong team within and around Bridges, from Board members, to graduate interns, to project-specific team members, as well as the diverse set of organizations with whom we have partnered. These collaborations enable us to have an outsized impact with a relatively small team. We have created strong organizational structures and systems, supporting the work we do and giving our partners and funders confidence in the way we operate. In this annual report, we summarize some key 2023 organizational and programmatic highlights, delving a bit deeper into six areas of Bridges’ work. Check out our 2023 Annual Report here: https://bit.ly/bridgesAR23 #globalhealth #sustainabledevelopment #resilientcommunities #beatNTDs #ImmunizationAgenda2030 STOP2030 #FGSchisto The Geneva Learning Foundation (TGLF)

What drives drug resistance in helminth parasites? These genetic researchers are looking for shared patterns between animals and humans that could help predict the emergence of resistance. Read their findings here https://lnkd.in/duUAx5Xf 

Get to know STOP2030 in the format you like ▶ In the words of our partners in our short video 🗺 Through our project brochure 🌐 With our latest research publications Find it all on our website! https://lnkd.in/dSzxg8r9 

With the potential development of a Malaria vaccine, hopes are rising for NTDs. What makes these infections so challenging in the field? Read the full story of vaccines and NTDs in this BBC feature  https://lnkd.in/ecUfTYdk

Risk groups in soil-transmitted helminths are often considered by age and gender, but other factors may also come into play. For example, work conditions. This study in Nigeria analyses the prevalence of STH in agrarian communities, a recently suggested risk group. Read the results here: https://lnkd.in/dGcnyjUp 

Last month, participants from all our partner organizations met in Kenya for the project’s Annual Meeting! Two days packed with discussions, and catch-ups after 12 months of intensive work to plan the next steps towards regulatory approval and implementation. Check out the details, as well as some pictures, on our website! https://lnkd.in/dqRCbvsw 

To achieve control and elimination goals for #NTDs, data is key 📋 Especially prediction models that help prepare and prevent infection spread. The NTD Modelling Consortium develops mathematical models to provide context to control plans — for e.g. the World Health Organization 2030 Roadmap. Now, this Consortium has just participated in a special supplement to accelerate NTD control. Read it here https://lnkd.in/dSVnifVq     

India is one of the few countries that celebrate a National Deworming Day 📆 It is celebrated February 10 every year since 2015. Learn all about the history and objectives of this day here ➡  https://lnkd.in/dFsT5C_j  

🙌🏽 Formamos parte del proyecto STOP2030 (Stopping Transmission Of intestinal Parasites) 🙌🏽 🤝 Una colaboración público-privada entre instituciones líderes de #Europa y #África que tiene como objetivo implementar un nuevo medicamento, dos en uno, para las helmintiasis transmitidas por el suelo. 🪱Este enfoque dual e innovador busca reducir los costos y aumentar la efectividad centrándose en cinco especies de #ParásitosIntestinales. Insud Insud Pharma Silvia Gold